In particular, we focused on BPF as a sepsis drug candidate because among the six NF-κB inhibitors in XBJI, BPF is (1) the most abundant component, (2) the most effective inhibitor of NF-κB activity, and (3) an inhibitor of COX-1 and COX-2 activities. This evidence concerns the gene NFKB1 and Sepsis.